Literature DB >> 4066057

Suppression of the allergic contact reaction in the guinea pig by cyclosporin A.

C Anderson, O Groth.   

Abstract

In a study of the effects of cyclosporin A on the allergic contact reaction to oxazolone in the guinea pig, a pronounced ability to suppress redness and edema and the dermal inflammatory cell infiltrate was demonstrated. At the generally recommended (human) organ transplantation immunosuppression dosage (20 mg/kg), a single dose gave no certain effect, but when repeated daily for 3 days, some suppression of the reaction was seen. A single 80 mg/kg dose produced marked suppression of erythema and edema and all components of the dermal cellular infiltrate. This effect was still evident, though less marked, 3 days after administration. The 80 mg/kg dose had no effect on the toxic contact reaction to croton oil. Of the agents we have previously tested (cyclophosphamide, methotrexate and azathioprine) with this model, cyclosporin A has by far the most marked capacity to suppress the allergic (cell-mediated) contact reaction, via a mechanism which would appear to involve immunomodulation rather than mere nonspecific anti-inflammatory effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066057     DOI: 10.1159/000233920

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Effects of topical cyclosporin A on guinea-pig toxic contact dermatitis.

Authors:  M Yokoo; D Oka; S Nakagawa
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Immunohistochemical analysis of contact sensitivity reactions in the guinea-pig using novel monoclonal antibodies: the influence of topical cyclosporin A.

Authors:  S N Payne; A W Thomson
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

3.  Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity.

Authors:  M Braida; J Knop
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.